Listed

MBX Biosciences, Inc.

MBXNasdaqCIK 1776111HealthcareFiscal year ends Dec 31

Reports and events: 56 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

MBX Biosciences, Inc., Reports and events
FiledFormWhat it isAccession number
2024-09-2316:34 ETSC 13DOwnership report, active investor0000947871-24-000767
2024-09-2310:48 ETSC 13DOwnership report, active investor0001193125-24-223402
2024-09-1616:21 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-24-219621
2024-09-0906:06 ETS-1/ARegistration statement, amended0001193125-24-215436
2024-08-3017:13 ETS-1/ARegistration statement, amended0001193125-24-211217
2024-08-2316:44 ETS-1Registration statement0001193125-24-206227

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 18:07 ET. Listed shows no prices and gives no investment advice.